Prompt and robust bone regeneration has been clinically achieved using supraphysiological doses of bone morphogenetic protein‐2 (BMP‐2) to overcome the short half‐life and rapid clearance. However, uncontrolled burst release of exogenous BMP‐2 causes severe complications such as heterotopic ossification and soft tissue inflammation. Therefore, numerous researches have focused on developing a new BMP‐2 delivery system for a sustained release profile by immobilizing BMP‐2 in various polymeric vehicles. Herein, to avoid denaturation of BMP‐2 and enhance therapeutic action via localized delivery, a complex coacervate consisting of fucoidan, a marine‐derived glycosaminoglycan, and poly‐l‐lysine (PLL) is fabricated. Superior BMP‐2 binding ability and electrostatic interaction‐driven engulfment enable facile and highly efficient microencapsulation of BMP‐2. The microencapsulation ability of the coacervate significantly improves BMP‐2 bioactivity and provides protection against antagonist and proteolysis, while allowing prolonged release. Moreover, BMP‐2 containing coacervate is coated on conventional collagen sponges. The bioactivity and localized bone regenerating ability are confirmed through in vitro (human‐derived stem cells), and in vivo (calvarial bone defect model) evaluations.
Inorganic–organic hybrid materials have promising properties for bone repair because of the covalent bonding between their inorganic and organic phases. This desirable interaction allows the limitations of composite materials, such as inhomogeneous biodegradation rates and nonbiointeractive surfaces, to be overcome. In this study, a polycaprolactone (PCL)-based polyurethane (PU) with an organosilane functional group was synthesized for the first time. Thereafter, a biodegradable PU-silica hybrid was produced through the sol-gel process. The PU-silica hybrid was not only flexible and fully biodegradable but also possessed shape memory ability. In addition, allophanate bonding enabled the silane coupling agent to induce increased crosslinking between the polymer and silica network, as well as between polymer and polymer. Accordingly, the sol-to-gel gelation time required to produce the hybrids was very short, which allowed the production of 3D porous hybrid scaffolds through a simple salt-leaching process. A hybrid scaffold with a 30 wt. % silica composition was the most ideal bone regenerative scaffold since it was able to withstand thermal deformation with promising mechanical properties. Moreover, the hybrid scaffold induced osteogenic differentiation and angiogenesis to accelerate bone regeneration.
The use of biodegradable materials in bone plates offers remarkable advantages; however, their application in bone fixation is limited by their brittleness. Moreover, treatments tailored to patient conditions are needed in orthopedics. In this study, bone plates were fabricated with stereocomplex polylactic acid (scPLA) and the effects of poly(d-lactic acid) molecular weight and scPLA blending ratios were analyzed. Although modulus values of poly(l-lactic acid) (PLLA) and scPLA were similar, strain resistance improved at higher scPLA proportions. The enhanced elongation was owing to the presence of tie molecules within the scPLA as opposed to single PLA chains. The fabricated scPLA bone plates exhibited improved mechanical properties and transparency in the optical and near-infrared ranges. scPLA was characterized by a smaller crystallite size. These properties of scPLA combined with its biocompatibility indicate potential for various diagnostic and therapeutic orthopedic applications. Comparisons with commercial PLLA-based bone plates show no significant differences in in vivo bone-healing ability.